876 related articles for article (PubMed ID: 16912303)
1. Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response.
Iankov ID; Pandey M; Harvey M; Griesmann GE; Federspiel MJ; Russell SJ
J Virol; 2006 Sep; 80(17):8530-40. PubMed ID: 16912303
[TBL] [Abstract][Full Text] [Related]
2. Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins.
Song MK; Vindurampulle CJ; Capozzo AV; Ulmer J; Polo JM; Pasetti MF; Barry EM; Levine MM
J Virol; 2005 Aug; 79(15):9854-61. PubMed ID: 16014946
[TBL] [Abstract][Full Text] [Related]
3. Measles virus protein-specific IgM, IgA, and IgG subclass responses during the acute and convalescent phase of infection.
El Mubarak HS; Ibrahim SA; Vos HW; Mukhtar MM; Mustafa OA; Wild TF; Osterhaus AD; de Swart RL
J Med Virol; 2004 Feb; 72(2):290-8. PubMed ID: 14695672
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of T cells as carriers for systemic measles virotherapy in the presence of antiviral antibodies.
Ong HT; Hasegawa K; Dietz AB; Russell SJ; Peng KW
Gene Ther; 2007 Feb; 14(4):324-33. PubMed ID: 17051248
[TBL] [Abstract][Full Text] [Related]
5. Neutralization capacity of measles virus H protein specific IgG determines the balance between antibody-enhanced infectivity and protection in microglial cells.
Iankov ID; Penheiter AR; Griesmann GE; Carlson SK; Federspiel MJ; Galanis E
Virus Res; 2013 Mar; 172(1-2):15-23. PubMed ID: 23266401
[TBL] [Abstract][Full Text] [Related]
6. Protection against challenge with measles virus (MV) in infant macaques by an MV DNA vaccine administered in the presence of neutralizing antibody.
Premenko-Lanier M; Rota PA; Rhodes GH; Bellini WJ; McChesney MB
J Infect Dis; 2004 Jun; 189(11):2064-71. PubMed ID: 15143474
[TBL] [Abstract][Full Text] [Related]
7. Mucosal adenovirus-vectored vaccine for measles.
Lobanova LM; Baig TT; Tikoo SK; Zakhartchouk AN
Vaccine; 2010 Nov; 28(48):7613-9. PubMed ID: 20887832
[TBL] [Abstract][Full Text] [Related]
8. Relative contributions of measles virus hemagglutinin- and fusion protein-specific serum antibodies to virus neutralization.
de Swart RL; Yüksel S; Osterhaus AD
J Virol; 2005 Sep; 79(17):11547-51. PubMed ID: 16103210
[TBL] [Abstract][Full Text] [Related]
9. Measles virus-induced promotion of dendritic cell maturation by soluble mediators does not overcome the immunosuppressive activity of viral glycoproteins on the cell surface.
Klagge IM; ter Meulen V; Schneider-Schaulies S
Eur J Immunol; 2000 Oct; 30(10):2741-50. PubMed ID: 11069053
[TBL] [Abstract][Full Text] [Related]
10. Measles virus targets DC-SIGN to enhance dendritic cell infection.
de Witte L; Abt M; Schneider-Schaulies S; van Kooyk Y; Geijtenbeek TB
J Virol; 2006 Apr; 80(7):3477-86. PubMed ID: 16537615
[TBL] [Abstract][Full Text] [Related]
11. Measles virus exploits dendritic cells to suppress CD4+ T-cell proliferation via expression of surface viral glycoproteins independently of T-cell trans-infection.
Dubois B; Lamy PJ; Chemin K; Lachaux A; Kaiserlian D
Cell Immunol; 2001 Dec; 214(2):173-83. PubMed ID: 12088416
[TBL] [Abstract][Full Text] [Related]
12. Transgenic mice expressing human HLA and CD8 molecules generate HLA-restricted measles virus cytotoxic T lymphocytes of the same specificity as humans with natural measles virus infection.
Tishon A; LaFace DM; Lewicki H; van Binnendijk RS; Osterhaus A; Oldstone MB
Virology; 2000 Sep; 275(2):286-93. PubMed ID: 10998329
[TBL] [Abstract][Full Text] [Related]
13. Measles Virus Hemagglutinin epitopes immunogenic in natural infection and vaccination are targeted by broad or genotype-specific neutralizing monoclonal antibodies.
Muñoz-Alía MA; Casasnovas JM; Celma ML; Carabaña J; Liton PB; Fernandez-Muñoz R
Virus Res; 2017 May; 236():30-43. PubMed ID: 28465158
[TBL] [Abstract][Full Text] [Related]
14. Protective immunity provided by HLA-A2 epitopes for fusion and hemagglutinin proteins of measles virus.
Oh S; Stegman B; Pendleton CD; Ota MO; Pan CH; Griffin DE; Burke DS; Berzofsky JA
Virology; 2006 Sep; 352(2):390-9. PubMed ID: 16781760
[TBL] [Abstract][Full Text] [Related]
15. Growth of 17D yellow fever virus in a macrophage-like cell line, U937: role of Fc and viral receptors in antibody-mediated infection.
Schlesinger JJ; Brandriss MW
J Immunol; 1981 Aug; 127(2):659-65. PubMed ID: 7252155
[TBL] [Abstract][Full Text] [Related]
16. Protection against measles virus-induced encephalitis by anti-mimotope antibodies: the role of antibody affinity.
Olszewska W; Obeid OE; Steward MW
Virology; 2000 Jun; 272(1):98-105. PubMed ID: 10873752
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of priming with DNA vaccines encoding the hemagglutinin and/or fusion proteins on cytokine responses after measles virus challenge.
Polack FP; Hoffman SJ; Moss WJ; Griffin DE
J Infect Dis; 2003 Jun; 187(11):1794-800. PubMed ID: 12751038
[TBL] [Abstract][Full Text] [Related]
18. Priming of measles virus-specific CTL responses after immunization with a CTL epitope linked to a fusogenic peptide.
Partidos CD; Vohra P; Steward MW
Virology; 1996 Jan; 215(1):107-10. PubMed ID: 8553582
[TBL] [Abstract][Full Text] [Related]
19. In Vivo Efficacy of Measles Virus Fusion Protein-Derived Peptides Is Modulated by the Properties of Self-Assembly and Membrane Residence.
Figueira TN; Palermo LM; Veiga AS; Huey D; Alabi CA; Santos NC; Welsch JC; Mathieu C; Horvat B; Niewiesk S; Moscona A; Castanho MARB; Porotto M
J Virol; 2017 Jan; 91(1):. PubMed ID: 27733647
[TBL] [Abstract][Full Text] [Related]
20. A chimeric alphavirus replicon particle vaccine expressing the hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques from measles.
Pan CH; Greer CE; Hauer D; Legg HS; Lee EY; Bergen MJ; Lau B; Adams RJ; Polo JM; Griffin DE
J Virol; 2010 Apr; 84(8):3798-807. PubMed ID: 20130066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
